## Abstract {.page_break_before}

Text.

## Summary points

- Affinity, valency, and other alterations to target cell binding only provide enganced selectivity in specific situations.
- Evidence for the effectiveness and limitations of each strategy are abundant within the drug development literature.
- Combining strategies can offer enhanced selectivity.
- A simple, multivalent antigen-receptor binding model can help to direct therapeutic engineering.

## Author Summary

More text.
